Viewing StudyNCT00171210



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00171210
Status: COMPLETED
Last Update Posted: 2011-05-30
First Post: 2005-09-12

Brief Title: An Extension Study of Iron Chelation Therapy With Deferasirox ICL670 in β-thalassemia Patients With Transfusional Iron Overload
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Transfusional Iron Overload in β-thalassemia
Keywords:
Name View
deferasirox View
β-thalassemia View
iron overload View